A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

NCT01072929 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

433

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: Armodafinil
DRUG: Placebo

Sponsor

Cephalon